Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial

Athimalaipet V Ramanan, Kamran Mahmood, Beverley Almeida

The Lancet · 2023 · 77 citations · 28 references

DOIFull text

Open access

Concepts

References

28